Advertisement
Screener

Verastem, Inc. (VSTM) Capital Expenditures

2.8 / 5 stars · 68/120 Roast Me

Verastem, Inc. Capital Expenditures

Verastem, Inc. (VSTM) reported Capital Expenditures of $28.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-04.

Financial Statements › Cash Flow › Investing Activities

us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-03-04

  • Verastem, Inc. payments to acquire property, plant, and equipment for the quarter ending 2024-12-31 was $0.00.
  • Verastem, Inc. payments to acquire property, plant, and equipment for the quarter ending 2024-09-30 was $0.00.
  • Verastem, Inc. payments to acquire property, plant, and equipment for the quarter ending 2024-06-30 was $7.00K.
  • Verastem, Inc. payments to acquire property, plant, and equipment for the quarter ending 2024-03-31 was $21.00K.
  • Verastem, Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $28.00K.
  • Verastem, Inc. payments to acquire property, plant, and equipment for fiscal 2021 was $196.00K, a 493.94% increase from fiscal 2020.
  • Verastem, Inc. payments to acquire property, plant, and equipment for fiscal 2020 was $33.00K, a 371.43% increase from fiscal 2019.
  • Verastem, Inc. payments to acquire property, plant, and equipment for fiscal 2019 was $7.00K, a 99.54% decline from fiscal 2018.
Period endPayments to Acquire Property, Plant, and Equipment 3 monthPayments to Acquire Property, Plant, and Equipment 5 monthPayments to Acquire Property, Plant, and Equipment 6 monthPayments to Acquire Property, Plant, and Equipment 9 monthPayments to Acquire Property, Plant, and Equipment 12 monthPayments to Acquire Property, Plant, and Equipment 20 monthPayments to Acquire Property, Plant, and Equipment 23 monthPayments to Acquire Property, Plant, and Equipment 26 monthPayments to Acquire Property, Plant, and Equipment 29 monthPayments to Acquire Property, Plant, and Equipment 32 monthPayments to Acquire Property, Plant, and Equipment 35 monthPayments to Acquire Property, Plant, and Equipment 38 monthPayments to Acquire Property, Plant, and Equipment 41 monthPayments to Acquire Property, Plant, and Equipment 44 month
2024-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04
$0.00
derived: sum of 2 quarters · filed 2026-03-04
$7.00K
derived: sum of 3 quarters · filed 2026-03-04
$28.00K
10-K · filed 2026-03-04
2024-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04
$7.00K
derived: sum of 2 quarters · filed 2025-11-04
$28.00K
10-Q · filed 2025-11-04
2024-06-30$7.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07
$28.00K
10-Q · filed 2025-08-07
2024-03-31$21.00K
10-Q · filed 2025-05-13
2021-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14
$0.00
derived: sum of 2 quarters · filed 2024-03-14
$0.00
derived: sum of 3 quarters · filed 2024-03-14
$196.00K
10-K · filed 2024-03-14
2021-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03
$0.00
derived: sum of 2 quarters · filed 2022-11-03
$196.00K
10-Q · filed 2022-11-03
$196.00K
derived: sum of 4 quarters · filed 2023-03-14
2021-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08
$196.00K
10-Q · filed 2022-08-08
$196.00K
derived: sum of 3 quarters · filed 2023-03-14
$202.00K
derived: sum of 4 quarters · filed 2023-03-14
2021-03-31$196.00K
10-Q · filed 2022-05-09
$196.00K
derived: sum of 2 quarters · filed 2023-03-14
$202.00K
derived: sum of 3 quarters · filed 2023-03-14
2020-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14
$6.00K
derived: sum of 2 quarters · filed 2023-03-14
$33.00K
10-K · filed 2023-03-14
2020-09-30$6.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04
$33.00K
10-Q · filed 2021-11-04
2020-06-30$27.00K
10-Q · filed 2021-08-02
2019-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28
$7.00K
10-K · filed 2022-03-28
2019-09-30$7.00K
10-Q · filed 2020-11-09
2018-12-31$263.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18
$830.00K
derived: sum of 2 quarters · filed 2021-03-18
$1.41M
derived: sum of 3 quarters · filed 2021-03-18
$1.51M
10-K · filed 2021-03-18
2018-09-30$567.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30
$1.14M
derived: sum of 2 quarters · filed 2019-10-30
$1.24M
10-Q · filed 2019-10-30
2018-06-30$575.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01
$677.00K
10-Q · filed 2019-08-01
2018-03-31$102.00K
10-Q · filed 2019-05-09
2016-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12
$39.00K
10-K · filed 2019-03-12
2016-09-30$39.00K
10-Q · filed 2017-11-07
2015-12-31$7.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13
$15.00K
derived: sum of 2 quarters · filed 2018-03-13
$15.00K
derived: sum of 3 quarters · filed 2018-03-13
$211.00K
10-K · filed 2018-03-13
2015-09-30$8.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07
$8.00K
derived: sum of 2 quarters · filed 2016-11-07
$204.00K
10-Q · filed 2016-11-07
$771.00K
derived: sum of 4 quarters · filed 2017-03-23
2015-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08
$196.00K
10-Q · filed 2016-08-08
$763.00K
derived: sum of 3 quarters · filed 2017-03-23
$2.21M
derived: sum of 4 quarters · filed 2017-03-23
2015-03-31$196.00K
10-Q · filed 2016-05-09
$763.00K
derived: sum of 2 quarters · filed 2017-03-23
$2.21M
derived: sum of 3 quarters · filed 2017-03-23
$2.62M
derived: sum of 4 quarters · filed 2017-03-23
2014-12-31$567.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-23
$2.02M
derived: sum of 2 quarters · filed 2017-03-23
$2.42M
derived: sum of 3 quarters · filed 2017-03-23
$2.43M
10-K · filed 2017-03-23
2014-09-30$1.45M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09
$1.85M
derived: sum of 2 quarters · filed 2015-11-09
$1.86M
10-Q · filed 2015-11-09
$1.88M
derived: sum of 4 quarters · filed 2016-03-03
2014-06-30$402.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10
$412.00K
10-Q · filed 2015-08-10
$432.00K
derived: sum of 3 quarters · filed 2016-03-03
$437.00K
derived: sum of 4 quarters · filed 2016-03-03
2014-03-31$10.00K
10-Q · filed 2015-05-11
$30.00K
derived: sum of 2 quarters · filed 2016-03-03
$35.00K
derived: sum of 3 quarters · filed 2016-03-03
$1.17M
10-Q · filed 2014-05-08
2013-12-31$20.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-03
$25.00K
derived: sum of 2 quarters · filed 2016-03-03
$56.00K
10-K · filed 2016-03-03
$1.16M
10-K · filed 2014-03-06
2013-09-30$5.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30
$36.00K
10-Q · filed 2014-10-30
$1.14M
10-Q · filed 2013-11-12
2013-06-30$31.00K
10-Q · filed 2014-08-07
$1.13M
10-Q · filed 2013-08-13
2013-03-31$1.10M
10-Q · filed 2013-05-09
2012-12-31-$11.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-10
$143.00K
derived: sum of 2 quarters · filed 2015-03-10
$180.00K
derived: sum of 3 quarters · filed 2015-03-10
$310.00K
10-K · filed 2015-03-10
$1.10M
10-K · filed 2013-03-26
2012-09-30$154.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12
$191.00K
derived: sum of 2 quarters · filed 2013-11-12
$321.00K
10-Q · filed 2013-11-12
$352.00K
derived: sum of 4 quarters · filed 2014-03-06
$1.11M
10-Q · filed 2012-11-13
2012-06-30$37.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-13
$167.00K
10-Q · filed 2013-08-13
$198.00K
derived: sum of 3 quarters · filed 2014-03-06
$567.00K
derived: sum of 4 quarters · filed 2014-03-06
$960.00K
10-Q · filed 2012-08-13
2012-03-31$130.00K
10-Q · filed 2013-05-09
$161.00K
derived: sum of 2 quarters · filed 2014-03-06
$530.00K
derived: sum of 3 quarters · filed 2014-03-06
$923.00K
10-Q · filed 2012-05-14
2011-12-31$31.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-06
$400.00K
derived: sum of 2 quarters · filed 2014-03-06
$785.00K
10-K · filed 2014-03-06
2011-09-30$369.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-13
$754.00K
10-Q · filed 2012-11-13
2011-06-30$385.00K
10-Q · filed 2012-08-13
2010-12-31$8.00K
10-K · filed 2013-03-26

Similar stocks

Stock NameCountryMarket CapPE Ratio
Nuvectis Pharma, Inc. (NVCT)United States$0.705B-17.53
IRONWOOD PHARMACEUTICALS INC (IRWD)United States$0.694B5.37
Climb Bio, Inc. (CLYM)United States$0.683B-13.03
COLLEGIUM PHARMACEUTICAL, INC (COLL)United States$0.737B24.57
ZEVRA THERAPEUTICS, INC. (ZVRA)United States$0.668B14.61
Faeth Therapeutics, Inc. (FTH)United States$0.750B
BlossomHill Therapeutics, Inc. (BLSM)United States$0.647B
Design Therapeutics, Inc. (DSGN)United States$0.766B-12.78
Shattuck Labs, Inc. (STTK)United States$0.634B-13.30
Wave Life Sciences, Inc. (WVE)$0.780B-5.56